Facts About Opiate Use in Pregnancy (PDF - 413 KB)
Provides an overview of neonatal abstinence syndrome (NAS) and how opiate exposure during pregnancy may affect a newborn.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Provides an overview of neonatal abstinence syndrome (NAS) and how opiate exposure during pregnancy may affect a newborn.
This is a toolkit on addressing pain in patients with opioid use disorder (OUD) and managing medication for addiction treatment (MAT) during the perioperative/postpartum period.
Addresses NAS, including maternal risk factors during pregnancy, social risk factors, assessment, and treatment.
Addresses concerns about prescription drug abuse and maternal-fetal exposure to opioids.
Provides information for treating pregnant and parenting women with OUD, as well as their infants.
Page 5 Use the links to move to the next, previous, first, or last page.